Efficacy of Empagliflozin as Add-on Therapy in Patients with Uncontrolled Type 2 Diabetes Mellitus. (2023). TAJ: Journal of Teachers Association, 36(1), 89-95. https://doi.org/10.3329/taj.v36i1.68304